Deparments of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Deparments of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Turk J Pediatr. 2020;62(6):940-948. doi: 10.24953/turkjped.2020.06.005.
In situations where it may take a long time to perform renal transplantation peritoneal dialysis may become a long-term maintenance treatment, especially in countries with low donor rates. Therefore, we aimed to evaluate peritonitis, catheter revision and survival rates in children on chronic peritoneal dialysis (CPD); and to define related factors in a single tertiary center from a WHO upper middle income country.
Between January 1998 and September 2018, data of pediatric patients receiving CPD with a followup longer than 3 months were retrospectively analyzed. Demographic, clinical and catheter-related data were collected. Patients were grouped as being operated before/after 2009 in order to evaluate the effects of 2 different periods on outcomes.
A total of 229 catheters in 132 patients were included in the study. The female to male ratio was 60/72. The mean age at the time of dialysis was 8.9 ± 5.5 years. The median follow-up period was 22.5 months (IQR 8.25-50; range 3-139). Peritonitis incidence in 1998-2008 and 2009-2018 periods was 0.13 episodes/patient-year and 0.09 episodes/ patient-year, respectively. The overall revision rate was 1 per 46.7 patient-months. Peritonitis history was the only independent risk factor for access revision (p=0.003). Peritoneal dialysis failure was observed in 25% (33/132) of patients. The need for catheter revision due to any cause, the presence of peritonitis, history of HD and infancy were independent risk factors for PD failure. The overall mortality rate was 15.2%(20/132). Having a history of temporary PD catheter placement and being infant were independent risk factors for mortality.
Access revision is still an important complication leading to PD failure despite the development of surgical techniques. Peritonitis is the most important cause of access revision and PD failure.
在进行肾移植可能需要很长时间的情况下,腹膜透析可能成为长期维持治疗,特别是在供体率较低的国家。因此,我们旨在评估来自世界卫生组织中等偏上收入国家的一家三级中心的儿童慢性腹膜透析(CPD)患者的腹膜炎、导管修订和生存率,并确定相关因素。
1998 年 1 月至 2018 年 9 月,回顾性分析接受 CPD 治疗且随访时间超过 3 个月的儿科患者数据。收集人口统计学、临床和导管相关数据。为了评估两个不同时期对结果的影响,将患者分为 2009 年之前/之后的两组。
共有 132 名患者的 229 根导管纳入研究。男女比例为 60/72。透析时的平均年龄为 8.9±5.5 岁。中位随访时间为 22.5 个月(IQR 8.25-50;范围 3-139)。1998-2008 年和 2009-2018 年期间腹膜炎发生率分别为 0.13 例/患者年和 0.09 例/患者年。总体修订率为每 46.7 患者月 1 次。腹膜炎病史是唯一独立的导管修订风险因素(p=0.003)。25%(33/132)的患者出现腹膜透析失败。需要修订导管的任何原因、腹膜炎、HD 病史和婴儿期都是 PD 失败的独立危险因素。总的死亡率为 15.2%(20/132)。临时 PD 导管放置史和婴儿期是死亡的独立危险因素。
尽管外科技术不断发展,但导管修订仍然是导致 PD 失败的重要并发症。腹膜炎是导致导管修订和 PD 失败的最重要原因。